Sponsor content
3 result(s) found, displaying 1 to 3
-
Prescription medicine decision summaryWezlana (ustekinumab) has been approved for the treatment of plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis.
-
Prescription medicine decision summaryTGA Decision: Lumakras (sotorasib) is approved to treat adult patients with non-small cell lung cancer (NSCLC).
-